Roche’s Evrysdi is a strong contender for SMA market share following EMA nod
Roche recently announced that its product Evrysdi (risdiplam) was recommended for approval for the treatment of spinal muscular atrophy (SMA) in patients two months of age and older by the...
UK Covid-19 Vaccine Administration at 300 shots per 1,000 population, while vaccine rates low elsewhere in europe
With new SARS-CoV-2 variant strains appearing, the global race to control the COVID-19 pandemic through immunization is on. Europe remains one of the worst affected regions in the world, now…